相关实验视频

Updated: May 5, 2026

Quantifying Leukocyte Egress via Lymphatic Vessels from Murine Skin and Tumors

Quantifying Leukocyte Egress via Lymphatic Vessels from Murine Skin and Tumors

Published on: January 7, 2019

黑色素瘤中的LRP2表达与过渡性细胞状态,增加的T细胞透,并由IFNy信号调节

Martin Q Rasmussen¹, Marie L Bønnelykke-Behrndtz^2,3, Camilla Merrild¹

¹Department of Biomedicine, Aarhus University, Aarhus, Denmark.

Pigment cell & melanoma research

|September 6, 2025

概括

低密度脂蛋白受体相关蛋白2 (LRP2) 在黑色素瘤中获得并与特定的细胞状态相关. 干扰因子信号驱动LRP2表达,与更好的黑色素瘤预后相关.

科学领域:

分子生物学
癌症研究
免疫学

背景情况:

低密度脂蛋白受体相关蛋白2 (LRP2) 是一种在发育和成年细胞中发现的内细胞受体.
在上皮癌中,LRP2表达与分化和改善的预后相关.
在良性瘤中没有LRP2,但在黑色素瘤中经常存在,因此需要对其驱动因素和特征进行研究.

研究的目的:

确定黑色素瘤中LRP2表达的分子驱动因素.
描述LRP2表达的黑色素瘤细胞.
探索LRP2表达与瘤微环境之间的关系,特别是T细胞炎症和干扰素马信号.

主要方法:

在黑色素瘤样本中分析LRP2表达.
转录分析以识别共同表达的基因程序.
对干扰素-信号通路的研究.
LRP2表达与临床病理变量如Breslow厚度和临床阶段的相关性.

主要成果:

黑色素瘤LRP2表达与短暂的细胞状态相关,同时表达黑色素细胞和神经转录程序.
在T细胞炎症的黑色素瘤中,LRP2表达升高.
干扰素直接提高黑色素瘤细胞中的LRP2表达.
初级黑色素瘤中的LRP2表达与较低的Breslow厚度和较低的临床阶段相关.

结论:

黑色素瘤中的LRP2表达与独特的细胞表型和有利的预后相关.
干扰素马信号传递是黑色素瘤中LRP2表达的关键调节者.
了解LRP2调节可以了解黑色素瘤的进展情况和潜在的治疗策略.

关键词:

在LRP2 差异化表观遗传学炎症的发生干扰素梅加林黑色素瘤

更多相关视频

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research

Published on: March 29, 2024

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

MAPK Signaling Cascades

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...